OncClubAll Oncology NewsPipeline Report
InsightsMedical World NewsOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsThe Talk
Conference CoverageConference Listing
Giants of Cancer CarePER EventsScientific InterchangesState of the Science Summit / IPCWebinars
Partners
Oncology Live®Oncology FellowsSupplements And Featured PublicationsAll Publications
CME/CE
Biomarker ConsortiumInteractive ToolsLearning ModulesPresentationsSponsored
Print SubscriptioneNewsletter
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
Business Management
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
Spotlight -
  • REGISTER TODAY to explore data on a novel second-generation BTK inhibitor for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
  • Share your views with OncChats
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
Business Management
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
    • Partners
    • CME/CE
Advertisement

A Practical Approach to the Treatment of Metastatic CRC

home / news-network / practical-approach-treatment-mcrc
Advertisement
Considering the Basics in Newly Diagnosed mCRC

EP. 1: Considering the Basics in Newly Diagnosed mCRC

March 29th 2019
Tissue-Based Testing Versus Liquid Biopsy in mCRC

EP. 2: Tissue-Based Testing Versus Liquid Biopsy in mCRC

March 29th 2019
Multidisciplinary Approach to Resection in mCRC

EP. 3: Multidisciplinary Approach to Resection in mCRC

March 29th 2019
Sequencing for BRAF+, RAS+, HER2- Left-Sided CRC

EP. 4: Sequencing for BRAF+, RAS+, HER2- Left-Sided CRC

March 29th 2019
The Influx of Younger Patients With Advanced CRC

EP. 5: The Influx of Younger Patients With Advanced CRC

March 29th 2019
Puzzling Together the Pieces in mCRC

EP. 6: Puzzling Together the Pieces in mCRC

March 29th 2019
Advertisement
Adjusting the Lines of Therapy Indication in mCRC

EP. 7: Adjusting the Lines of Therapy Indication in mCRC

March 29th 2019
Optimizing Dosing in Patients With mCRC

EP. 8: Optimizing Dosing in Patients With mCRC

March 29th 2019
Dosing Strategies and Patient Support in mCRC

EP. 9: Dosing Strategies and Patient Support in mCRC

March 29th 2019
Improving Responsiveness With Immunotherapy in mCRC

EP. 10: Improving Responsiveness With Immunotherapy in mCRC

March 29th 2019
Refinement of Techniques and the Future of mCRC

EP. 11: Refinement of Techniques and the Future of mCRC

March 29th 2019

Latest Conference Coverage

Isa-KRd Elicits MRD-Negative Remissions in Newly Diagnosed, High-Risk Myeloma

KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis

Smoldering Multiple Myeloma Management Hinges on the Debate Between Treatment and Observation

Lung Responses to Atezolizumab/Bevacizumab Linked With OS in HCC and Pulmonary Metastasis

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact